Trends in Biotechnology · Sep 3, 2026
Advancing European standards and regulations for 3D bioprinting
By Maddalon A, Leonetti G, Zimmer S
3D bioprinting has the potential to provide nonanimal alternatives to preclinical testing and revolutionize current clinical and transplantation practices. Realizing this potential requires a concerted effort to develop and advance European standards and regulatory frameworks, ensuring a clear and safe pathway for the clinical integration of 3D bioprinting.
doi.org/10.1016/j.tibtech.2026.08.001Open accessPubMed 42692932Industry & policy